BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 29, 2000
View Archived Issues
Research points to existence of a third hereditary breast cancer gene
Read More
Carbapenems display potent and broad antianaerobic activity
Read More
Scientists uncover vital role of activin A in neuroprotection after brain injury
Read More
Neurotransmitter inhibits food intake in rats
Read More
Ceramide-coated catheters significantly reduce restenosis in vivo
Read More
Orally bioavailable potassium (IKs) blockers synthesized by Bristol-Myers Squibb
Read More
More potent and selective PDE5 inhibitors developed
Read More
Novel potent and selective beta3-adrenergic receptor agonists described
Read More
Inflazyme updates shareholders on product development progress
Read More
Topical Paclitaxel Gel found safe in two phase I psoriasis trials
Read More
LifeTime Pharmaceuticals announces U.S. phase I/II trials of Beta LT for cancer
Read More
Hormone replacement therapy shows no cardiovascular benefits in older women
Read More
Advanced Tissue Sciences submits PMA for Dermagraft as treatment of diabetic foot ulcers
Read More
Allergan in-licenses gatifloxacin from Kyorin for treatment of ocular infections
Read More
New compounds interacting with 5-HT1 receptors reported by Pfizer
Read More
New compounds under study at Merck useful for dyslipidemias, etc.
Read More
Potent, selective muscarinic M3 receptor antagonists patented by Mitsubishi-Tokyo
Read More
Actonel approved in Canada
Read More
Vitamin D3 derivatives claimed by Teijin for treatment of cystic fibrosis
Read More
AMPA/kainate receptor modulators claimed by Egis
Read More
V1A/V2 receptor antagonist conivaptan in the news
Read More
InKine changes trade name of Diacol to Visicol
Read More
Rigel and Novartis establish drug discovery agreement for respiratory therapies
Read More
Results of dosing studies on tezosentan in CHF reported
Read More
Mast cell tryptase explored as a marker in stable CAD
Read More
Vion begins additional phase I trial of intravenous TAPET
Read More